Global Biopharmaceuticals Market 2011-2015

$ 2 000 - July 2012 - by Infiniti Research Limited - 57

Summary

Table of Contents

View Report

Search Inside

TechNavio's analysts forecast the Global Biopharmaceuticals market to grow at a CAGR of 4.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased adoption of advanced technologies. The Global Biopharmaceuticals market has also been witnessing the trend of an increase in RandD activities. However, patent expiration of top-selling drugs could pose a challenge to the growth of this market.



TechNavio's report, the Global Biopharmaceuticals Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biopharmaceuticals landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.



Key vendors dominating this market space include Pfizer Inc., Abbott Laboratories Inc., Sanofi S.A., AstraZeneca plc, and Johnson and Johnson Services Inc. Other vendors in the market are GlaxoSmithKline plc, Merck Sereno S.A., UCB S.A., and Boehringer Ingelheim GmbH.



Key questions answered in this report:

What will the market size be in 2015 and at what rate will it grow?

What key trends is this market subject to?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the opportunities and threats faced by each of these key vendors?

What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

BUY THIS REPORT

ASK INFO SPECIALIST 24/7
Robyn - online now
00 1 718 213 49 04
Send Message @Robyn

Share

Global Biopharmaceutical Industry : Latest Reports

Analytical Tool - Antibodies and Peptides in Oncology

Analytical Tool - Antibodies and Peptides in Oncology

  • $ 8 925
  • Industry report
  • April 2013
  • by Bioseeker

"Analytical Tool - Antibodies and Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and ...

Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

  • $ 4 650
  • Industry report
  • March 2013
  • by MarketsandMarkets

Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently ...

Triple Analysis: Cancer Vaccines, Antibodies and Peptides

Triple Analysis: Cancer Vaccines, Antibodies and Peptides

  • $ 5 175
  • Industry report
  • March 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Cancer Vaccines and by the two compound strategies of Antibodies and Peptides. Each of these three individual ...


Global Biopharmaceutical Industry : Latest Downloads

Enzyme Sector Analysis

Enzyme Sector Analysis

  • Industry report
  • March 2013
  • 90 pages

... Production Preparation of enzymes 21/03/2013 why enzymes Catalysts increase the rate of reactions without any net change in their structure. Concept of catalysis is developed as early as the 19th ...

Biopharmaceutical Industry Brief

Biopharmaceutical Industry Brief

  • Industry report
  • October 2012
  • 8 pages

... Alfa was non-inferior to imiglucerase if the lower limit of the one-sided 97.5% Confidence interval (ci) of the treatment difference (velaglucerase alfa minus imiglucerase) was greater than -1 g ...

Biopharmaceutical Sector Brief

Biopharmaceutical Sector Brief

  • Industry report
  • October 2012
  • 6 pages

... E in upstream and downstream development. As an example of pharmaceutical proteins whole production processes of potential malaria vaccines are investigated in detail. In the field of technical enzymes ...

Antibody Market Brief

8 months ago

Related Market Segments :

Monoclonal Antibody
Growth Hormone

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.